Apyx Medical Stock (NASDAQ:APYX)
Previous Close
$4.61
52W Range
$1.59 - $5.08
50D Avg
$3.88
200D Avg
$3.48
Market Cap
$194.71M
Avg Vol (3M)
$176.17K
Beta
1.39
Div Yield
-
APYX Company Profile
Apyx Medical Corporation, an energy technology firm established in 1982 and headquartered in Clearwater, Florida, focuses on the development, manufacturing, and global sale of medical devices for both the aesthetic and surgical fields. The company operates through two main divisions: Advanced Energy and Original Equipment Manufacturing (OEM). Among its key innovations is the Helium Plasma Generator, which delivers a controlled combination of RF energy and helium to precisely cut, coagulate, and ablate soft tissue in open and laparoscopic surgical procedures. For the cosmetic surgery market, Apyx Medical offers its Renuvion product line, enabling plastic surgeons and other aesthetic practitioners to apply targeted heat for desired patient outcomes. Concurrently, the J-Plasma brand caters specifically to the hospital surgical sector. Furthermore, the company designs, produces, and sells disposable hand pieces, alongside OEM generators and their related accessories. The entity was previously known as Bovie Medical Corporation, changing its name to Apyx Medical Corporation in January 2019.